Literature DB >> 22288826

Sertraline inhibits pre-synaptic Na⁺ channel-mediated responses in hippocampus-isolated nerve endings.

Blanca I Aldana1, María Sitges.   

Abstract

In the present study, a possible sertraline action on cerebral pre-synaptic Na(+) channels was investigated. For this purpose, the effect of sertraline on responses induced by the Na(+) channel opener, veratridine, namely the increase in Na(+) and in neurotransmitter release in hippocampus-isolated nerve endings was investigated. Results show that sertraline in the low μM range (1.5-25 μM) progressively inhibits the rise in Na(+) and the release of pre-loaded [(3) H]Glu as well as the release of endogenous 5-HT, Glu and GABA (detected by HPLC) induced by veratridine depolarization either under external Ca(2+) -free conditions or in the presence of external Ca(2+) . In addition, under non-depolarized conditions, sertraline (25 μM) increased the external concentration of 5-HT at expense of its internal concentration, and unchanged the external and internal concentrations of the amino acid neurotransmitters and of the 5-HT main metabolite, 5-HIAA. This result is consistent with the sertraline inhibitory action of the serotonin transporter. However, sertraline is unlikely to inhibit pre-synaptic Na(+) channels permeability by increasing external 5-HT. Because 5-HT in a wide concentration range (1-1000 μM) did not change the veratridine-induced increase in Na(+) . In summary, present findings demonstrate that besides the inhibition of 5-HT reuptake, sertraline is an effective inhibitor of pre-synaptic Na(+) channels controlling neurotransmitter release.
© 2012 The Authors. Journal of Neurochemistry © 2012 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22288826     DOI: 10.1111/j.1471-4159.2012.07674.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Identifying Treatment Response of Sertraline in a Teenager with Selective Mutism using Electrophysiological Neuroimaging.

Authors:  Andy R Eugene; Jolanta Masiak
Journal:  Int J Clin Pharmacol Toxicol       Date:  2016-06-15

2.  Effects of Levetiracetam, Carbamazepine, Phenytoin, Valproate, Lamotrigine, Oxcarbazepine, Topiramate, Vinpocetine and Sertraline on Presynaptic Hippocampal Na(+) and Ca(2+) Channels Permeability.

Authors:  María Sitges; Luz María Chiu; Ronald C Reed
Journal:  Neurochem Res       Date:  2015-11-05       Impact factor: 3.996

3.  Effect of the Anti-depressant Sertraline, the Novel Anti-seizure Drug Vinpocetine and Several Conventional Antiepileptic Drugs on the Epileptiform EEG Activity Induced by 4-Aminopyridine.

Authors:  Maria Sitges; Blanca Irene Aldana; Ronald Charles Reed
Journal:  Neurochem Res       Date:  2016-01-30       Impact factor: 3.996

4.  PharmGKB summary: sertraline pathway, pharmacokinetics.

Authors:  Rachel Huddart; J Kevin Hicks; Laura B Ramsey; Jeffrey R Strawn; D Max Smith; Margarita Bobonis Babilonia; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2020-02       Impact factor: 2.000

5.  Sertraline reduces IL-1β and TNF-α mRNA expression and overcomes their rise induced by seizures in the rat hippocampus.

Authors:  María Sitges; Carlos D Gómez; Blanca I Aldana
Journal:  PLoS One       Date:  2014-11-03       Impact factor: 3.240

6.  Can a Selective Serotonin Reuptake Inhibitor Act as a Glutamatergic Modulator?

Authors:  Marcos Emilio Frizzo
Journal:  Curr Ther Res Clin Exp       Date:  2017-07-08

7.  Sertraline Induces Toxicity and Behavioral Alterations in Planarians.

Authors:  Isabela Salvador Thumé; Marcos Emílio Frizzo
Journal:  Biomed Res Int       Date:  2017-05-24       Impact factor: 3.411

8.  A Thorough QT Study to Evaluate the Effects of a Supratherapeutic Dose of Sertraline on Cardiac Repolarization in Healthy Subjects.

Authors:  Richat Abbas; Steve Riley; Robert R LaBadie; Mary Bachinsky; Phillip B Chappell; Penelope H Crownover; Bharat Damle
Journal:  Clin Pharmacol Drug Dev       Date:  2019-11-27

9.  Major channels involved in neuropsychiatric disorders and therapeutic perspectives.

Authors:  Paola Imbrici; Diana Conte Camerino; Domenico Tricarico
Journal:  Front Genet       Date:  2013-05-07       Impact factor: 4.599

10.  Blockade of Kv1.5 channels by the antidepressant drug sertraline.

Authors:  Hyang Mi Lee; Sang June Hahn; Bok Hee Choi
Journal:  Korean J Physiol Pharmacol       Date:  2016-02-23       Impact factor: 2.016

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.